实控人拟变更为张现涛，盟科药业盘中涨逾15%

Group 1 - The core point of the article is that Mengke Pharmaceutical's stock price surged over 15% following the announcement of a significant share issuance agreement with Haijing Pharmaceutical [1] - Mengke Pharmaceutical's stock price reached 9.28 yuan per share, reflecting a 14.71% increase at the time of reporting [1] - Haijing Pharmaceutical plans to subscribe to 164 million ordinary shares of Mengke Pharmaceutical, which will result in Haijing holding a 20% stake in the company [1] Group 2 - Following the share issuance, Haijing Pharmaceutical will become the controlling shareholder of Mengke Pharmaceutical [1] - The natural person Zhang Xiantao will become the actual controller of Mengke Pharmaceutical after the completion of the share issuance [1]